Life sciences organizations often engage key opinion leaders (KOLs) and healthcare professionals (HCPs) to help develop new medications and devices through participation in speaker programs, consulting roles, advisory boards, and other interactions. These engagements come with risks to regulatory compliance and reputation. To help organizations mitigate and manage these risks, PYA offers a Checklist for Life Sciences Organizations Engaging Key Opinion Leaders and Healthcare Professionals.
PYA’s checklist serves as a guide to assist organizations in evaluating both the payment to and process for engaging KOLs and HCPs. The convenient checklist allows users to answer “Yes” or “No” to questions in these areas:
- Engagement process: pre-approval, service definition, documentation of need
- Fair market value: consistency, objectivity, uniformity, exceptions
- Specific interactions: speaker program, advisory board, consulting, other
The checklist helps pharmaceutical, medical device, medtech, and other life sciences organizations objectively evaluate key items prior to engagement and payment for services to KOLs and HCPs. It also helps the organizations identify areas that might need more consideration before the engagement takes place.
PYA helps organizations mitigate risks and manage regulatory requirements during engagements with healthcare providers and other professionals. If your organization needs assistance with contracts, payment, fair market value, or any issue related to compliance or strategy, our executives are happy to assist.
